Crucial roles in the diagnosis and functionality of GC are played by biomarkers like claudin 18.2 (CLDN 18.2), HER2, mucin 1, natural killer receptor group 2, epithelial cell adhesion molecule, mesothelin, and CEA [42,52]. This evidence concerns the gene ERBB2 and gastric cancer.